Literature DB >> 16326901

Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptor.

Jérôme Hénin1, Bernard Maigret, Mounir Tarek, Chantal Escrieut, Daniel Fourmy, Christophe Chipot.   

Abstract

A three-dimensional model structure of a complex formed by a G-protein-coupled receptor (GPCR) and an agonist ligand is probed and refined using molecular-dynamics simulations and free energy calculations in a realistic environment. The model of the human receptor of cholecystokinin associated to agonist ligand CCK9 was obtained from a synergistic procedure combining site-directed mutagenesis experiments and in silico modeling. The 31-ns molecular-dynamics simulation in an explicit membrane environment indicates that both the structure of the receptor and its interactions with the ligand are robust. Whereas the secondary structure of the alpha-helix bundle is well preserved, the region of the intracellular loops exhibits a significant flexibility likely to be ascribed to the absence of G-protein subunits in the model. New insight into the structural features of the binding pocket is gained, in particular, the interplay of the ligand with both the receptor and internal water molecules. Water-mediated interactions are shown to participate in the binding, hence, suggesting additional site-directed mutagenesis experiments. Accurate free energy calculations on mutated ligands provide differences in the receptor-ligand binding affinity, thus offering a direct, quantitative comparison to experiment. We propose that this detailed consistency-checking procedure be used as a routine refinement step of in vacuo GPCR models, before further investigation and application to structure-based drug design.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326901      PMCID: PMC1367274          DOI: 10.1529/biophysj.105.070599

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

Review 1.  Target validation of G-protein coupled receptors.

Authors:  Alan Wise; Katy Gearing; Stephen Rees
Journal:  Drug Discov Today       Date:  2002-02-15       Impact factor: 7.851

Review 2.  Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.

Authors:  Daniel Fourmy; Chantal Escrieut; Elodie Archer; Céline Galès; Véronique Gigoux; Bernard Maigret; Luis Moroder; Sandrine Silvente-Poirot; Jean Martinez; Jean-Alain Fehrentz; Lucien Pradayrol
Journal:  Pharmacol Toxicol       Date:  2002-12

Review 3.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.

Authors:  J Ballesteros; K Palczewski
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

Review 4.  Modeling the 3D structure of GPCRs: advances and application to drug discovery.

Authors:  Oren M Becker; Sharon Shacham; Yael Marantz; Silvia Noiman
Journal:  Curr Opin Drug Discov Devel       Date:  2003-05

Review 5.  Molecular tinkering of G protein-coupled receptors: an evolutionary success.

Authors:  J Bockaert; J P Pin
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

Review 6.  Enhancing the accuracy, the efficiency and the scope of free energy simulations.

Authors:  Tomas Rodinger; Régis Pomès
Journal:  Curr Opin Struct Biol       Date:  2005-04       Impact factor: 6.809

7.  Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor.

Authors:  C Giragossian; D F Mierke
Journal:  Biochemistry       Date:  2001-04-03       Impact factor: 3.162

Review 8.  This is not a G protein-coupled receptor.

Authors:  M F Hibert; S Trumpp-Kallmeyer; J Hoflack; A Bruinvels
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

9.  Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

Authors:  Elodie Archer-Lahlou; Irina Tikhonova; Chantal Escrieut; Marlène Dufresne; Catherine Seva; Lucien Pradayrol; Luis Moroder; Bernard Maigret; Daniel Fourmy
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

10.  Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.

Authors:  K Kennedy; V Gigoux; C Escrieut; B Maigret; J Martinez; L Moroder; D Fréhel; D Gully; N Vaysse; D Fourmy
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

View more
  18 in total

1.  Building a foundation for structure-based cellulosome design for cellulosic ethanol: Insight into cohesin-dockerin complexation from computer simulation.

Authors:  Jiancong Xu; Michael F Crowley; Jeremy C Smith
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

2.  Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.

Authors:  Stefano Costanzi; Irina G Tikhonova; T Kendall Harden; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2008-05-16       Impact factor: 3.686

3.  By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.

Authors:  Xavier Iturrioz; Romain Gerbier; Vincent Leroux; Rodrigo Alvear-Perez; Bernard Maigret; Catherine Llorens-Cortes
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Exploring the binding pocket for pyridopyrimidine ligands at the CCK1 receptor by molecular docking.

Authors:  Amel Toumi-Maouche; Boubekeur Maouche; Safia Taïri-Kellou; Salima El-Aoufi; Mercedes Martín-Martínez; Rosario González-Muñiz; Daniel Fourmy; Bernard Maigret
Journal:  J Mol Model       Date:  2008-02-20       Impact factor: 1.810

5.  Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study.

Authors:  Shannon E Telesco; Ravi Radhakrishnan
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

6.  Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Authors:  Yvette Dehnes; Jufang Shan; Thijs Beuming; Lei Shi; Harel Weinstein; Jonathan A Javitch
Journal:  Neurochem Int       Date:  2014-02-24       Impact factor: 3.921

7.  A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.

Authors:  Bipasha Guptaroy; Minjia Zhang; Erica Bowton; Francesca Binda; Lei Shi; Harel Weinstein; Aurelio Galli; Jonathan A Javitch; Richard R Neubig; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2008-12-19       Impact factor: 4.436

8.  Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.

Authors:  Kaleeckal G Harikumar; Fan Gao; Delia I Pinon; Laurence J Miller
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

9.  Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor.

Authors:  Fan Gao; Patrick M Sexton; Arthur Christopoulos; Laurence J Miller
Journal:  Bioorg Med Chem Lett       Date:  2008-06-20       Impact factor: 2.823

10.  Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.

Authors:  Maoqing Dong; Laurence J Miller
Journal:  Peptides       Date:  2013-06-14       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.